Results 61 to 70 of about 700,979 (308)

The Swiss Primary Ciliary Dyskinesia registry: objectives, methods and first results

Swiss Medical Weekly, 2019
Primary ciliary dyskinesia (PCD) is a rare, hereditary, multiorgan disease caused by defects in the structure and function of motile cilia. It results in a wide range of clinical manifestations, most commonly in the upper and lower airways.
Myrofora Goutaki, Marc O. Eich, Florian S. Halbeisen, Juerg Barben, Carmen Casaulta, Christian Clarenbach, Gaudenz Hafen, Philipp Latzin, Nicolas Regamey, Romain Lazor, Stefan Tschanz, Maura Zanolari, Elisabeth Maurer, Claudia E. Kuehni, for the Swiss PCD Registry (CH-PCD) Working Group   +14 more
doaj   +1 more source

Precaution, governance and the failure of medical implants: the ASR(TM) hip in the UK [PDF]

, 2014
Hip implants have provided life-changing treatment, reducing pain and improving the mobility and independence of patients. Success has encouraged manufacturers to innovate and amend designs, engendering patient hopes in these devices.
Joyce, Thomas, McCormack, Pauline, Wienroth, Matthias   +2 more
core   +1 more source

Prehospital critical care is associated with increased survival in adult trauma patients in Scotland [PDF]

, 2020
Background Scotland has three prehospital critical care teams (PHCCTs) providing enhanced care support to a usually paramedic-delivered ambulance service.
Carr, David, Corfield, Alasdair R., Donald, Michael J., Fitzpatrick, David, Hearns, Stephen, Lyon, Richard M., Maddock, Alistair, Sinclair, Neil   +7 more
core   +3 more sources

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

Analysis of the current status of patient registry studies in China [PDF]

Yixue xinzhi zazhi
Objective To analyze the current status of patient registry studies conducted in China, and to provide reference basis for improvement of patient registry studies.Methods Patient registry studies in China were searched in ClinicalTrials.gov, and the time
YI Hongbin, NIE Zhifeng, HAN Sheng, SHI Luwen   +3 more
doaj   +1 more source

Evaluating hospital performance based on excess cause-specific incidence [PDF]

, 2015
Formal evaluation of hospital performance in specific types of care is becoming an indispensable tool for quality assurance in the health care system.
Eriksson, Marie, Goetghebeur, Els, Van Rompaye, Bart   +2 more
core   +1 more source

Patient registries for substance use disorders

Substance Abuse and Rehabilitation, 2014
This commentary discusses the need for developing patient registries of substance use disorders (SUD) in general medical settings. A patient registry is a tool that documents the natural history of target diseases. Clinicians and researchers use registries to monitor patient comorbidities, care procedures and processes, and treatment effectiveness for ...
Tai, Betty, Lindblad,Robert, VanVeldhuisen,Paul, Hu,Lian, Sparenborg,Steven, GHitza,Udi   +5 more
openaire   +5 more sources

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry

Orphanet Journal of Rare Diseases, 2016
Background Patients are becoming increasingly involved in research which can promote innovation through novel ideas, support patient-centred actions, and facilitate drug development.
Len Woodward, Sally Johnson, Johan Vande Walle, Joran Beck, Christoph Gasteyger, Christoph Licht, Gema Ariceta, on behalf of the aHUS Registry SAB   +7 more
doaj   +1 more source

Barnes Hospital Bulletin [PDF]

, 1980
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1171/thumbnail ...

core   +1 more source